Literature DB >> 11723132

Molecular interactions of biglycan and decorin with elastic fiber components: biglycan forms a ternary complex with tropoelastin and microfibril-associated glycoprotein 1.

Betty Reinboth1, Eric Hanssen, Edward G Cleary, Mark A Gibson.   

Abstract

The interactions of the dermatan sulfate proteoglycans biglycan and decorin have been investigated with the elastic fiber components, tropoelastin, fibrillin-containing microfibrils, and microfibril-associated glycoproteins (MAGP) 1 and 2. Both proteoglycans were found to bind tropoelastin and fibrillin-containing microfibrils but not MAGPs 1 and 2 in solid phase binding assays. The specificity of the binding of biglycan and decorin to tropoelastin was confirmed by co-immunoprecipitation experiments and by the blocking of the interactions with elastin-derived peptides. Isolated core proteins from biglycan and decorin bound to tropoelastin more strongly than the intact proteoglycans, and there were no differences in the tropoelastin binding characteristics of distinct glucuronate-rich and iduronate-rich glycoforms of biglycan. These findings indicated that the binding sites were contained in the protein cores of the proteoglycans rather than the glycosaminoglycan side chains. Scatchard analysis showed that biglycan bound more avidly than decorin to tropoelastin with K(d) values estimated as 1.95 x 10(-7) m and 5.3 x 10(-7) m, respectively. In blocking experiments each proteoglycan showed extensive inhibition of binding of the other to tropoelastin but was most effective at blocking its own binding. This result suggested that biglycan and decorin had closely spaced but distinct binding sites on tropoelastin. Addition of the elastin-binding protein MAGP-1 to the assays enhanced the binding of biglycan to tropoelastin but had no effect on the decorin-tropoelastin interaction. Co-immunoprecipitation experiments showed that MAGP-1 interacted with biglycan but not decorin in the solution phase. The results indicated that biglycan specifically formed a ternary complex with tropoelastin and MAGP-1. Overall the study supports the concept that biglycan may have a specific role in the elastinogenic phase of elastic fiber formation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11723132     DOI: 10.1074/jbc.M109540200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

Review 1.  Fibrillin-rich microfibrils: elastic biopolymers of the extracellular matrix.

Authors:  C M Kielty; T J Wess; L Haston; Jane L Ashworth; M J Sherratt; C A Shuttleworth
Journal:  J Muscle Res Cell Motil       Date:  2002       Impact factor: 2.698

Review 2.  Extracellular matrix composition reveals complex and dynamic stromal-epithelial interactions in the mammary gland.

Authors:  Ori Maller; Holly Martinson; Pepper Schedin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-09-02       Impact factor: 2.673

3.  Rare copy number variants disrupt genes regulating vascular smooth muscle cell adhesion and contractility in sporadic thoracic aortic aneurysms and dissections.

Authors:  Siddharth K Prakash; Scott A LeMaire; Dong-Chuan Guo; Ludivine Russell; Ellen S Regalado; Hossein Golabbakhsh; Ralph J Johnson; Hazim J Safi; Anthony L Estrera; Joseph S Coselli; Molly S Bray; Suzanne M Leal; Dianna M Milewicz; John W Belmont
Journal:  Am J Hum Genet       Date:  2010-11-18       Impact factor: 11.025

4.  Differential availability/processing of decorin precursor in arterial and venous smooth muscle cells.

Authors:  Rafaella Franch; Angela Chiavegato; Maddalena Maraschin; Serena Candeo; Simonetta Ausoni; Antonello Villa; Gino Gerosa; Lisa Gasparotto; Pierpaolo Parnigotto; Saverio Sartore
Journal:  J Anat       Date:  2006-09       Impact factor: 2.610

Review 5.  Decorin interacting network: A comprehensive analysis of decorin-binding partners and their versatile functions.

Authors:  Maria A Gubbiotti; Sylvain D Vallet; Sylvie Ricard-Blum; Renato V Iozzo
Journal:  Matrix Biol       Date:  2016-09-30       Impact factor: 11.583

6.  Proteoglycans and catabolic products of proteoglycans present in ligament.

Authors:  Mirna Z Ilic; Phillip Carter; Alicia Tyndall; Jayesh Dudhia; Christopher J Handley
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

7.  Biglycan deficiency: increased aortic aneurysm formation and lack of atheroprotection.

Authors:  Tao Tang; Joel C Thompson; Patricia G Wilson; Meghan H Yoder; Julia Müeller; Jens W Fischer; Kevin Jon Williams; Lisa R Tannock
Journal:  J Mol Cell Cardiol       Date:  2014-08-02       Impact factor: 5.000

Review 8.  Soluble biglycan as a biomarker of inflammatory renal diseases.

Authors:  Louise Tzung-Harn Hsieh; Madalina-Viviana Nastase; Jinyang Zeng-Brouwers; Renato V Iozzo; Liliana Schaefer
Journal:  Int J Biochem Cell Biol       Date:  2014-08-01       Impact factor: 5.085

9.  Retrovirally mediated overexpression of glycosaminoglycan-deficient biglycan in arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointimae after vascular injury.

Authors:  Jin-Yong Hwang; Pamela Y Johnson; Kathleen R Braun; Aleksander Hinek; Jens W Fischer; Kevin D O'Brien; Barry Starcher; Alexander W Clowes; Mervyn J Merrilees; Thomas N Wight
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

10.  Mice lacking the extracellular matrix protein MAGP1 display delayed thrombotic occlusion following vessel injury.

Authors:  Claudio C Werneck; Cristina P Vicente; Justin S Weinberg; Adrian Shifren; Richard A Pierce; Thomas J Broekelmann; Douglas M Tollefsen; Robert P Mecham
Journal:  Blood       Date:  2008-02-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.